| review article | Q7318358 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1012134474 |
| P356 | DOI | 10.1007/S000110050495 |
| P698 | PubMed publication ID | 10563466 |
| P2093 | author name string | Nilsson BO | |
| P433 | issue | 10 | |
| P304 | page(s) | 509-515 | |
| P577 | publication date | 1999-10-01 | |
| P1433 | published in | Inflammation Research | Q1819367 |
| P1476 | title | Biological effects of aminoguanidine: an update | |
| P478 | volume | 48 |
| Q48241756 | (R)-α-Lipoic acid inhibits fructose-induced myoglobin fructation and the formation of advanced glycation end products (AGEs) in vitro |
| Q37424977 | A combined-cross analysis reveals genes with drug-specific and background-dependent effects on drug sensitivity in Saccharomyces cerevisiae |
| Q44368321 | AGE-breakers cleave model compounds, but do not break Maillard crosslinks in skin and tail collagen from diabetic rats |
| Q39333783 | Acinetobacter calcoaceticus-baumannii complex strains induce caspase-dependent and caspase-independent death of human epithelial cells |
| Q38243632 | Advanced glycation end product accumulation: a new enemy to target in chronic kidney disease? |
| Q30677061 | Age-related alterations of cardiac tissue microstructure and material properties in Fischer 344 rats |
| Q62086351 | Aminoguanidine Administration Ameliorates Hippocampal Damage After Middle Cerebral Artery Occlusion in Rat |
| Q45784169 | Aminoguanidine changes hippocampal expression of apoptosis-related genes, improves passive avoidance learning and memory in streptozotocin-induced diabetic rats. |
| Q37127122 | Aminoguanidine impedes human pancreatic tumor growth and metastasis development in nude mice. |
| Q35566544 | Aminoguanidine prevents arterial stiffening and cardiac hypertrophy in streptozotocin-induced diabetes in rats. |
| Q36052796 | Aminoguanidine prevents fructose-induced deterioration in left ventricular-arterial coupling in Wistar rats. |
| Q36736336 | Aminoguanidine prevents the impairment of cardiac pumping mechanics in rats with streptozotocin and nicotinamide-induced type 2 diabetes |
| Q42909616 | Aminoguanidine reduces oxidative stress and structural lung changes in experimental diabetes mellitus |
| Q90600230 | Analgesic Effect of Valerian Root and Turnip Extracts |
| Q38993911 | Antiapoptotic effect of aminoguanidine on doxorubicin-induced apoptosis |
| Q50117388 | Attenuation of Glucose-Induced Myoglobin Glycation and the Formation of Advanced Glycation End Products (AGEs) by (R)-α-Lipoic Acid In Vitro |
| Q36495879 | Beneficial effects of aminoguanidine on skin flap survival in diabetic rats |
| Q83812020 | Beneficial effects of banana (Musa sp. var. elakki bale) flower and pseudostem on hyperglycemia and advanced glycation end-products (AGEs) in streptozotocin-induced diabetic rats |
| Q43853065 | Beneficial role of amino acids in mitigating cytoskeletal actin glycation and improving F-actin content: in vitro |
| Q43923319 | Blood glucose- and triglyceride-lowering effect of trans-dehydrocrotonin, a diterpene from Croton cajucara Benth., in rats |
| Q37157673 | Cells and tissue interactions with glycated collagen and their relevance to delayed diabetic wound healing |
| Q43777338 | Chelating activity of advanced glycation end-product inhibitors |
| Q44426592 | Copper induces type II nitric oxide synthase in vivo |
| Q30013723 | DFT study of the mechanism of the reaction of aminoguanidine with methylglyoxal |
| Q44573540 | Dietary glycotoxins correlate with circulating advanced glycation end product levels in renal failure patients |
| Q41901450 | Dietary phenolics as reactive carbonyl scavengers: potential impact on human health and mechanism of action. |
| Q34463791 | Differential effects of LPS from Escherichia coli and Porphyromonas gingivalis on IL-6 production in human periodontal ligament cells |
| Q45016977 | Effect of antioxidants and ACE inhibition on chemical modification of proteins and progression of nephropathy in the streptozotocin diabetic rat. |
| Q50510477 | Effect of chronic intraperitoneal aminoguanidine on memory and expression of Bcl-2 family genes in diabetic rats. |
| Q37279651 | Effects of iNOS inhibitor on IFN-gamma production and apoptosis of splenocytes in genetically different strains of mice infected with Toxoplasma gondii |
| Q44195920 | Effects of nitric oxide synthase inhibitors and melatonin on the hyperglycemic response to streptozotocin in rats. |
| Q43758841 | Expression of the inducible isoform of nitric oxide synthase in the retinas of human subjects with diabetes mellitus |
| Q35887541 | Glycated collagen cross-linking alters cardiac mechanics in volume-overload hypertrophy |
| Q58775747 | Improved Methods for the Rapid Formation and Prevention of Advanced Glycation End Products (AGEs) In Vitro by Coupling to the Hypoxanthine/Xanthine Oxidase Assay System |
| Q35546284 | Improved cardiovascular function with aminoguanidine in DOCA-salt hypertensive rats |
| Q46602167 | Increased accumulation of skin advanced glycation end-products precedes and correlates with clinical manifestation of diabetic neuropathy |
| Q44545177 | Inducible nitric oxide synthase activity induced by sodium chloride solution prolongs luminal pH elevation in rat and mouse stomachs |
| Q42808155 | Induction of inducible nitric oxide synthase by Epstein-Barr virus B95-8-derived LMP1 in Balb/3T3 cells promotes stress-induced cell death and impairs LMP1-mediated transformation |
| Q44601471 | Inhibition of advanced glycation end‐products protects against retinal capillary basement membrane expansion during long‐term diabetes |
| Q34182424 | Integrin-specific mechanoresponses to compression and extension probed by cylindrical flat-ended AFM tips in lung cells |
| Q53254711 | Intraperitoneal aminoguanidine improves sciatic nerve ischemia-reperfusion injury in male sprague-dawley rats. |
| Q42714463 | Is There NO Treatment For Severe Sepsis? |
| Q34463493 | Is nitric oxide overproduction the target of choice for the management of septic shock? |
| Q36474508 | Membrane and nuclear permeabilization by polymeric pDNA vehicles: efficient method for gene delivery or mechanism of cytotoxicity? |
| Q36835542 | Nitric oxide in shock |
| Q47552730 | Nitric oxide induced by Indian ginseng root extract inhibits Infectious Bursal Disease virus in chicken embryo fibroblasts in vitro |
| Q44614840 | Nitric oxide synthase inhibitors modulate lipopolysaccharide-induced hepatocyte injury: dissociation between in vivo and in vitro effects |
| Q38700889 | Non-enzymatic glycation of bone collagen modifies osteoclastic activity and differentiation. |
| Q34572256 | Oral Administration of Semicarbazide Limits Weight Gain together with Inhibition of Fat Deposition and of Primary Amine Oxidase Activity in Adipose Tissue |
| Q73763318 | Pyridoxamine, an inhibitor of advanced glycation reactions, also inhibits advanced lipoxidation reactions. Mechanism of action of pyridoxamine |
| Q45918596 | Resorcylidene aminoguanidine induces antithrombotic action that is not dependent on its antiglycation activity. |
| Q38006722 | Role of advanced glycation endproducts and potential therapeutic interventions in dialysis patients |
| Q43141764 | Role of nitric oxide in hyperpnea-induced bronchoconstriction and airway microvascular permeability in guinea pigs. |
| Q35837652 | Semicarbazide-sensitive amine oxidase: role in the vasculature and vasodilation after in situ inhibition |
| Q28271097 | Simple non-invasive assessment of advanced glycation endproduct accumulation |
| Q46613148 | Simple noninvasive measurement of skin autofluorescence |
| Q40967301 | The effect of aminoguanidine on sperm motility and mitochondrial membrane potential in varicocelized rats |
| Q34348813 | The role of AGEs in aging: causation or correlation |
| Q34481838 | Therapeutic potential of AGE inhibitors and breakers of AGE protein cross-links |
| Q40118251 | Toxoplasma gondii infection induces apoptosis in noninfected macrophages: role of nitric oxide and other soluble factors. |
| Q36514906 | Uremic Toxicity of Advanced Glycation End Products in CKD. |
Search more.